Demant Croissance future

Future contrôle des critères 3/6

Demant devrait augmenter ses bénéfices et son chiffre d'affaires de 12.4% et de 6.1% par an respectivement. Le BPA devrait croître de de 15.5% par an. Le rendement des capitaux propres devrait être 28.1% dans 3 ans.

Informations clés

12.4%

Taux de croissance des bénéfices

15.5%

Taux de croissance du BPA

Medical Equipment croissance des bénéfices	18.6%
Taux de croissance des recettes	6.1%
Rendement futur des capitaux propres	28.1%
Couverture par les analystes	Good
Dernière mise à jour	15 Nov 2024

Mises à jour récentes de la croissance future

Recent updates

Demant A/S' (CPH:DEMANT) Intrinsic Value Is Potentially 97% Above Its Share Price

Jun 03

We Think Demant (CPH:DEMANT) Can Stay On Top Of Its Debt

May 22

Investors Still Waiting For A Pull Back In Demant A/S (CPH:DEMANT)

Apr 26

Is Now An Opportune Moment To Examine Demant A/S (CPH:DEMANT)?

Mar 18

Capital Allocation Trends At Demant (CPH:DEMANT) Aren't Ideal

Mar 06

Here's Why We Think Demant (CPH:DEMANT) Is Well Worth Watching

Feb 22

Demant (CPH:DEMANT) Has A Pretty Healthy Balance Sheet

Feb 08

Demant A/S (CPH:DEMANT) Not Flying Under The Radar

Jan 22

A Look At The Fair Value Of Demant A/S (CPH:DEMANT)

Jan 04

At kr.302, Is Demant A/S (CPH:DEMANT) Worth Looking At Closely?

Dec 17

Some Investors May Be Worried About Demant's (CPH:DEMANT) Returns On Capital

Oct 31

Is Demant (CPH:DEMANT) Using Too Much Debt?

Oct 16

Demant A/S' (CPH:DEMANT) Intrinsic Value Is Potentially 34% Above Its Share Price

Oct 01

Here's What's Concerning About Demant's (CPH:DEMANT) Returns On Capital

Jul 26

Is Now An Opportune Moment To Examine Demant A/S (CPH:DEMANT)?

Jul 11

A Look At The Fair Value Of Demant A/S (CPH:DEMANT)

Jun 26

Here's Why Demant (CPH:DEMANT) Can Manage Its Debt Responsibly

Jun 13

Demant (CPH:DEMANT) May Have Issues Allocating Its Capital

Apr 18

Is It Too Late To Consider Buying Demant A/S (CPH:DEMANT)?

Apr 04

Are Investors Undervaluing Demant A/S (CPH:DEMANT) By 25%?

Mar 21

These 4 Measures Indicate That Demant (CPH:DEMANT) Is Using Debt Reasonably Well

Mar 08

Demant A/S' (CPH:DEMANT) Intrinsic Value Is Potentially 77% Above Its Share Price

Dec 06

Capital Investments At Demant (CPH:DEMANT) Point To A Promising Future

Nov 22

We Think Demant (CPH:DEMANT) Can Stay On Top Of Its Debt

Oct 04

Does Demant (CPH:DEMANT) Deserve A Spot On Your Watchlist?

Sep 20

Demant A/S' (CPH:DEMANT) Intrinsic Value Is Potentially 95% Above Its Share Price

Sep 07

What Is Demant A/S's (CPH:DEMANT) Share Price Doing?

Aug 19

Many Would Be Envious Of Demant's (CPH:DEMANT) Excellent Returns On Capital

Jul 18

Demant (CPH:DEMANT) Seems To Use Debt Rather Sparingly

Jun 22

Demant A/S (CPH:DEMANT) Shares Could Be 42% Below Their Intrinsic Value Estimate

Jun 09

If You Like EPS Growth Then Check Out Demant (CPH:DEMANT) Before It's Too Late

May 28

Is Now The Time To Look At Buying Demant A/S (CPH:DEMANT)?

May 16

Shareholders Are Optimistic That Demant (CPH:DEMANT) Will Multiply In Value

Apr 09

Is Demant (CPH:DEMANT) A Risky Investment?

Mar 16

Shareholders Would Not Be Objecting To Demant A/S' (CPH:DEMANT) CEO Compensation And Here's Why

Mar 03

Is There An Opportunity With Demant A/S' (CPH:DEMANT) 23% Undervaluation?

Mar 01

Should You Be Adding Demant (CPH:DEMANT) To Your Watchlist Today?

Feb 17

What Does Demant A/S's (CPH:DEMANT) Share Price Indicate?

Feb 05

Capital Investment Trends At Demant (CPH:DEMANT) Look Strong

Jan 05

Does Demant (CPH:DEMANT) Have A Healthy Balance Sheet?

Dec 08

Estimating The Fair Value Of Demant A/S (CPH:DEMANT)

Nov 13

Is Now An Opportune Moment To Examine Demant A/S (CPH:DEMANT)?

Oct 31

Capital Investments At Demant (CPH:DEMANT) Point To A Promising Future

Oct 04

These 4 Measures Indicate That Demant (CPH:DEMANT) Is Using Debt Safely

Sep 08

Is It Time To Consider Buying Demant A/S (CPH:DEMANT)?

Jul 26

Prévisions de croissance des bénéfices et des revenus

CPSE:DEMANT - Estimations futures des analystes et données financières antérieures (DKK Millions )
Date	Recettes	Les revenus	Flux de trésorerie disponible	Cash from Op	Moy. Nombre d'analystes
12/31/2026	25,845	3,453	3,460	4,656	15
12/31/2025	24,035	3,075	3,148	4,202	17
12/31/2024	22,427	2,490	2,699	3,671	15
6/30/2024	22,836	2,535	2,836	3,644	N/A
3/31/2024	22,640	2,544	3,130	3,957	N/A
12/31/2023	22,443	2,552	3,424	4,270	N/A
9/30/2023	21,442	2,577	2,932	3,815	N/A
6/30/2023	20,902	2,488	2,462	3,387	N/A
3/31/2023	20,304	2,381	1,954	2,878	N/A
12/31/2022	19,705	2,274	1,445	2,369	N/A
9/30/2022	19,181	2,460	1,581	2,472	N/A
6/30/2022	18,656	2,645	1,716	2,575	N/A
3/31/2022	18,281	2,671	2,135	2,927	N/A
12/31/2021	17,905	2,696	2,553	3,279	N/A
9/30/2021	17,521	2,453	2,663	3,341	N/A
6/30/2021	17,137	2,209	2,772	3,403	N/A
3/31/2021	15,803	1,665	2,356	3,012	N/A
12/31/2020	14,469	1,121	1,940	2,621	N/A
9/30/2020	14,072	970	1,507	2,226	N/A
6/30/2020	13,674	818	1,073	1,831	N/A
3/31/2020	14,310	1,140	1,228	1,990	N/A
12/31/2019	14,946	1,462	1,383	2,149	N/A
9/30/2019	14,728	1,579	1,218	1,942	N/A
6/30/2019	14,510	1,695	1,052	1,734	N/A
3/31/2019	14,224	1,759	1,059	1,709	N/A
12/31/2018	13,937	1,823	1,065	1,683	N/A
9/30/2018	13,699	1,836	1,268	1,833	N/A
6/30/2018	13,461	1,849	1,471	1,982	N/A
3/31/2018	13,325	1,802	N/A	1,927	N/A
12/31/2017	13,189	1,754	N/A	1,872	N/A
9/30/2017	12,943	1,689	N/A	1,855	N/A
6/30/2017	12,697	1,624	N/A	1,837	N/A
3/31/2017	12,350	1,542	N/A	1,758	N/A
12/31/2016	12,002	1,459	N/A	1,679	N/A
9/30/2016	11,717	1,429	N/A	1,622	N/A
6/30/2016	11,432	1,399	N/A	1,565	N/A
3/31/2016	11,049	1,418	N/A	1,579	N/A
12/31/2015	10,665	1,436	N/A	1,592	N/A
9/30/2015	10,258	1,402	N/A	1,568	N/A
6/30/2015	9,850	1,367	N/A	1,544	N/A
3/31/2015	9,598	1,347	N/A	1,520	N/A
12/31/2014	9,346	1,326	N/A	1,495	N/A
9/30/2014	9,221	1,301	N/A	1,380	N/A
6/30/2014	9,095	1,275	N/A	1,265	N/A
3/31/2014	9,027	1,280	N/A	1,274	N/A
12/31/2013	8,959	1,285	N/A	1,282	N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: La croissance des bénéfices prévue de DEMANT ( 12.4% par an) est supérieure au taux d'épargne ( 1.2% ).

Bénéfices vs marché: Les bénéfices de DEMANT ( 12.4% par an) devraient croître plus rapidement que le marché Danish ( 11.6% par an).

Croissance élevée des bénéfices: Les bénéfices de DEMANT devraient augmenter, mais pas de manière significative.

Chiffre d'affaires vs marché: Le chiffre d'affaires de DEMANT ( 6.1% par an) devrait croître plus lentement que le marché de Danish ( 10% par an).

Croissance élevée des revenus: Le chiffre d'affaires de DEMANT ( 6.1% par an) devrait croître plus lentement que 20% par an.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: Le retour sur capitaux propres de DEMANT devrait être élevé dans 3 ans ( 28.1 %)

Demant Croissance future

Future contrôle des critères 3/6

Informations clés

Mises à jour récentes de la croissance future

Demant A/S Updates Earnings Guidance for the Year 2024

Demant A/S Provides Earnings Guidance for the Year 2024

Demant A/S Provides Earnings Guidance for the Year 2023

Price target increased by 7.4% to kr.286

Price target decreased to kr.230

Demant A/S Revised Earnings Guidance for the Full Year of 2022

Recent updates

Demant (CPH:DEMANT) Is Reinvesting At Lower Rates Of Return

When Should You Buy Demant A/S (CPH:DEMANT)?

Why Investors Shouldn't Be Surprised By Demant A/S' (CPH:DEMANT) P/E

Demant A/S Appoints Anne-Karen Hunt as President of Diagnostics Business Area, Effective 1 November 2024

Is There An Opportunity With Demant A/S' (CPH:DEMANT) 42% Undervaluation?

Demant A/S Announces Board Changes

Is Demant (CPH:DEMANT) Using Too Much Debt?

First half 2024 earnings released: EPS: kr.6.18 (vs kr.6.14 in 1H 2023)

Demant A/S Updates Earnings Guidance for the Year 2024

Investor sentiment deteriorates as stock falls 18%

Demant (CPH:DEMANT) May Have Issues Allocating Its Capital

Here's Why We Think Demant (CPH:DEMANT) Might Deserve Your Attention Today

At kr.326, Is It Time To Put Demant A/S (CPH:DEMANT) On Your Watch List?

Demant A/S' (CPH:DEMANT) Intrinsic Value Is Potentially 97% Above Its Share Price

We Think Demant (CPH:DEMANT) Can Stay On Top Of Its Debt

Cochlear Limited (ASX:COH) acquired Oticon Medical A/s from Demant A/S (CPSE:DEMANT).

Demant A/S Provides Earnings Guidance for the Year 2024

Investors Still Waiting For A Pull Back In Demant A/S (CPH:DEMANT)

Now 20% undervalued

Is Now An Opportune Moment To Examine Demant A/S (CPH:DEMANT)?

Capital Allocation Trends At Demant (CPH:DEMANT) Aren't Ideal

Here's Why We Think Demant (CPH:DEMANT) Is Well Worth Watching

Demant (CPH:DEMANT) Has A Pretty Healthy Balance Sheet

Full year 2023 earnings: EPS misses analyst expectations

Anja Madsen Announces Not to Stand for Re-Election to the Board of Directors of Demant A/S

Demant A/S (CPH:DEMANT) Not Flying Under The Radar

A Look At The Fair Value Of Demant A/S (CPH:DEMANT)

At kr.302, Is Demant A/S (CPH:DEMANT) Worth Looking At Closely?

Demant A/S to Report Nine Months, 2024 Results on Nov 04, 2024

Now 21% undervalued after recent price drop

Demant A/S Provides Earnings Guidance for the Year 2023

Some Investors May Be Worried About Demant's (CPH:DEMANT) Returns On Capital

Is Demant (CPH:DEMANT) Using Too Much Debt?

Demant A/S' (CPH:DEMANT) Intrinsic Value Is Potentially 34% Above Its Share Price

Now 21% undervalued

Price target increased by 7.4% to kr.286

First half 2023 earnings released: EPS: kr.5.63 (vs kr.5.07 in 1H 2022)

Here's What's Concerning About Demant's (CPH:DEMANT) Returns On Capital

Is Now An Opportune Moment To Examine Demant A/S (CPH:DEMANT)?

Now 21% undervalued

A Look At The Fair Value Of Demant A/S (CPH:DEMANT)

Demant A/S Announces Executive Changes

Here's Why Demant (CPH:DEMANT) Can Manage Its Debt Responsibly

Now 21% undervalued

Investor sentiment improves as stock rises 16%

Demant (CPH:DEMANT) May Have Issues Allocating Its Capital

Is It Too Late To Consider Buying Demant A/S (CPH:DEMANT)?

Now 20% undervalued

Are Investors Undervaluing Demant A/S (CPH:DEMANT) By 25%?

These 4 Measures Indicate That Demant (CPH:DEMANT) Is Using Debt Reasonably Well

Full year 2022 earnings: EPS misses analyst expectations

Investor sentiment improves as stock rises 16%

Demant A/S to Report Fiscal Year 2022 Results on Feb 07, 2023

Demant A/S' (CPH:DEMANT) Intrinsic Value Is Potentially 77% Above Its Share Price

Capital Investments At Demant (CPH:DEMANT) Point To A Promising Future

Less than half of directors are independent

Price target decreased to kr.230

Demant A/S Revised Earnings Guidance for the Full Year of 2022

Price target decreased to kr.264

We Think Demant (CPH:DEMANT) Can Stay On Top Of Its Debt

Does Demant (CPH:DEMANT) Deserve A Spot On Your Watchlist?

Demant A/S' (CPH:DEMANT) Intrinsic Value Is Potentially 95% Above Its Share Price

What Is Demant A/S's (CPH:DEMANT) Share Price Doing?

Demant A/S Revises Earnings Guidance for the Full Year 2022

Many Would Be Envious Of Demant's (CPH:DEMANT) Excellent Returns On Capital

Demant (CPH:DEMANT) Seems To Use Debt Rather Sparingly

Investor sentiment deteriorated over the past week

Demant A/S (CPSE:DEMANT) acquired remaining 80% interest in ShengWang for CNY.

Demant A/S (CPH:DEMANT) Shares Could Be 42% Below Their Intrinsic Value Estimate